Makoto Sumiyoshi Selected Research

Makoto Sumiyoshi Research Topics

2	COVID-19 08/2023 - 01/2023
2	Invasive Candidiasis 12/2020 - 10/2020
2	Neoplasms (Cancer) 11/2017 - 01/2017
1	Spotted Fever Group Rickettsiosis (Rickettsialpox) 04/2024
1	Hematuria 04/2024
1	Rhabdomyolysis 04/2024
1	Sepsis (Septicemia) 12/2023
1	Candidiasis (Moniliasis) 04/2023
1	Diarrhea 01/2023
1	Tachycardia (Tachyarrhythmias) 01/2022
1	Infections 10/2020
1	Lung Neoplasms (Lung Cancer) 11/2017
1	Erythema 11/2017
1	Xeroderma Pigmentosum (Kaposi's Disease) 01/2017
1	Sarcoma (Soft Tissue Sarcoma) 01/2017

2	Caspofungin (Cancidas)FDA Link 04/2023 - 10/2020
1	Ciprofloxacin (Cipro)FDA LinkGeneric 04/2024
1	CreatinineIBA 04/2024
1	Minocycline (Cyclops)FDA LinkGeneric 04/2024
1	Phosphotransferases (Kinase)IBA 04/2024
1	IronIBA 08/2023
1	AcidsIBA 08/2023
1	Phosphates (Orthophosphate)IBA 08/2023
1	Therapeutic UsesIBA 04/2023
1	Antiviral Agents (Antivirals)IBA 01/2023
1	Nelfinavir (Viracept)FDA Link 01/2023
1	C-Reactive ProteinIBA 01/2022
1	SterolsIBA 12/2020
1	ChemokinesIBA 12/2020
1	Micafungin (FK463)FDA Link 10/2020
1	EchinocandinsIBA 10/2020
1	Anidulafungin FDA Link 10/2020
1	Antifungal AgentsIBA 10/2020
1	NivolumabIBA 11/2017
1	Cisplatin (Platino)FDA LinkGeneric 01/2017
1	Biomarkers (Surrogate Marker)IBA 01/2017
1	Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA 01/2017

3	Catheters 12/2023 - 01/2017
1	Drug Therapy (Chemotherapy) 01/2017